Practice Analysis of Care, Paraclinical Exams and Treatments Received by Geriatric Patients Both During the Last Week and the Last 24 Hours of Their Lives.

End-of-life care is a core topic for geriatricians. One of the key aspects of end-of-life management is deciding when to discontinue active care measures (for example blood pressure monitoring, blood tests and X-rays) in favor of exclusive comfort care. In this retrospective observational study, the investigators looked at the care measures, treatments and paraclinical exams received by geriatric patients both one week and 24 hours before their death.

Study Overview

Status

Recruiting

Conditions

Detailed Description

This analysis provides information on the differences in geriatric physicians' practices regarding the anticipation of the end of life, by showing on average when active care measures were stopped before death. Secondly, the investigators looked at patient criteria that could explain a prolongation of active care and a delay in the implementation of exclusive comfort care.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Saint-Étienne, France
        • Recruiting
        • CHU Saint-Etienne
        • Sub-Investigator:
          • Ludovic LAFAIE, MD
        • Contact:
        • Contact:
        • Principal Investigator:
          • Solène VALETTE, resident

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All patients over 75 years old who died in the geriatric short-stay departments of Saint-Etienne University Hospital

Description

Inclusion Criteria:

  • All patients over 75 years old who died in a geriatric short-stay department at Saint-Etienne University Hospital.

Exclusion Criteria:

- Patients under 75 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients over 75 who died in geriatrics
Patients over 75 years old who died in the geriatric short-stay departments of Saint-Etienne University Hospital
Patient's socio-demographic data (age, gender, residence), comorbidities, cause of death, date and frequency of care measures/treatments/paraclinical exams received before their death.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of care and treatments received during the last week of life, and during the last 24 hours of life
Time Frame: In the last week of life and 24 hours before death
To measure the prevalence of care (hemodynamic, biological and radiological monitoring), and to evaluate the treatments received during the last week of life, and during the last 24 hours of life of patients hospitalized and who died in a geriatric short-stay ward.
In the last week of life and 24 hours before death

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient criteria that may have explained the pursuit of care
Time Frame: In the last week of life and 24 hours before death
Analysis of patient criteria (age, comorbidities, etc.) that may have explained the continuation of care, treatments and paraclinical exams up to the last 24 hours before death.
In the last week of life and 24 hours before death

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ludovic LAFAIE, MD, CHU Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

August 30, 2023

First Submitted That Met QC Criteria

August 30, 2023

First Posted (Actual)

September 7, 2023

Study Record Updates

Last Update Posted (Actual)

March 8, 2024

Last Update Submitted That Met QC Criteria

March 7, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRBN1162023/CHUSTE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End-of-life Care

Clinical Trials on Collecting data from the medical record

3
Subscribe